Lindsay A. Rosenwald M.D., Director at AVENUE THERAPEUTICS, INC. (ATXI), bought 64,800 shares at $4.32 ($278K) on 2018-06-07, disclosed to the SEC on 2018-06-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.15 | 8,666 | $36K | 12.9% |
| 2 | $4.19 | 3,800 | $16K | 5.7% |
| 3 | $4.28 | 8,400 | $36K | 12.9% |
| 4 | $4.35 | 9,100 | $40K | 14.2% |
| 5 | $4.32 | 14,800 | $64K | 23.0% |
| 6 | $4.32 | 14,800 |
| $64K |
| 23.0% |
| 7 | $4.34 | 5,234 | $23K | 8.2% |
| Total | $4.29 avg | 64,800 | $278K | 100% |
| Filing → |
| FBIO | BUY | 2024-05-20 | $18K | — | Filing → |
| DERM | BUY | 2024-03-27 | $30K | — | Filing → |
| DERM | BUY | 2024-03-25 | $68K | — | Filing → |